Sino Biopharmaceutical Limited (00314.HK) spent approximately 198,100 Hong Kong dollars on repurchasing 50,000 shares on June 5th.

The Zhixin Finance APP news reported that SP Health(00314.HK) announced the repurchase of 50,000 shares at a cost of approximately HK$198,100 on June 5, 2025.